Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Global Market Value Of The Hemochromatosis (Iron Overload) Disease Treatment Industry In 2025?
The hemochromatosis (iron overload) disease treatment market has demonstrated consistent expansion in recent years. This market is set to increase from $27.91 billion in 2024 to $28.62 billion in 2025, reflecting a compound annual growth rate (CAGR) of 2.6%. The historical growth trajectory is primarily a result of heightened clinical awareness and improved diagnosis, advancements in therapeutic options, wider genetic screening and earlier detection, the ongoing prevalence of hereditary hemochromatosis, and continuous research and clinical trials.
The hemochromatosis (iron overload) disease treatment market is projected to experience consistent expansion over the upcoming years. This market is predicted to reach ” $33.12 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 3.7%. Factors driving this growth during the forecast period include personalized medicine strategies, progress in therapeutic innovations, enhanced screening and public awareness campaigns, cooperative efforts in genetic research, and worldwide health initiatives. Key trends anticipated in the upcoming period encompass a heightened focus on educating and informing patients, the investigation of genetic and molecular therapeutic options, the utilization of telemedicine and remote patient monitoring, the incorporation of digital health platforms, and the worldwide broadening of access to treatment.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13151&type=smp
What Are The Main Drivers Boosting The Hemochromatosis (Iron Overload) Disease Treatment Industry’s Expansion?
The rising incidence of anemia is expected to propel the growth of the hemochromatosis (iron overload) disease treatment market. Anemia, a blood condition, is defined by a reduced number of red blood cells (RBCs) or a decreased amount of hemoglobin in the blood, leading to an inability to supply oxygen to the body’s organs and tissues. Treatment for hemochromatosis (iron overload) disease aims to prevent anemia using iron chelator medications, thereby avoiding organ damage and other complications associated with blood disorders. For instance, in December 2023, the World Health Organization (WHO), a Switzerland-based agency, estimated that 40% of children aged 6 to 59 months, 37% of pregnant women, and 30% of women aged 15 to 49 worldwide are affected by anemia. Thus, the increasing presence of anemia will drive the growth of the hemochromatosis (iron overload) disease treatment market.
How Is The Hemochromatosis (Iron Overload) Disease Treatment Market Classified Into Different Segments?
The hemochromatosis (iron overload) disease treatmentmarket covered in this report is segmented –
1) By Type: Hereditary Hemochromatosis; Acquired Hemochromatosis
2) By Treatment: Therapeutic Phlebotomy; Iron Chelation Therapy; Other Treatments
3) By End-Users: Hospitals; Surgical Centers; Other End-Users
Subsegments:
1) By Hereditary Hemochromatosis: Genetic Counseling; Phlebotomy; Chelation Therapy
2) By Acquired Hemochromatosis: Treatment Of Underlying Conditions; Phlebotomy; Chelation Therapy
What Key Innovation Trends Are Fueling Advancements In The Hemochromatosis (Iron Overload) Disease Treatment Market?
Key companies operating in the hemochromatosis (iron overload) disease treatment market are obtaining approvals for drugs like deferiprone, designed for patients experiencing transfusional iron overload to reduce excess iron levels in the body and avert complications linked to iron accumulation, such as organ damage. Deferiprone is a medication utilized to manage iron overload in individuals who have received numerous blood transfusions, often observed in conditions including thalassemia, sickle cell anemia, or other chronic anemias. As an example, in March 2023, Chiesi Global Rare Diseases Inc, a US-based business unit, announced the approval of FERRIPROX MR (deferiprone) extended-release tablets in Canada. FERRIPROX MR is indicated for the treatment of transfusional iron overload in patients with thalassemia syndromes when current chelation therapy is inadequate, as well as those with sickle cell disease (SCD) or other types of anemia. Deferiprone functions as an orally active iron-chelating agent, effectively lowering iron concentration in the body by penetrating cell membranes and binding to surplus iron, thus facilitating its removal from organs and tissues.
Who Are The Top Performing Companies In The Hemochromatosis (Iron Overload) Disease Treatment Market In Recent Years?
Major companies operating in the hemochromatosis (iron overload) disease treatment market report are Pfizer Inc., AbbVie Inc., Novartis AG, Fresenius Kabi AG, Abbott Laboratories, Merck KGaA, Laboratory Corporation, Quest Diagnostics, Chiesi Farmaceutici S.p.A., Apotex Inc., Shire PLC, CSL Vifor, ARUP Laboratories, Myriad Genetics Inc., Fulgent Genetics, Ionis Pharmaceuticals Inc., Invitae Corp., Abcam plc., GeneDx, Ambry Genetics, La Jolla Pharmaceutical Company, Silence Therapeutics, PreventionGenetics, DisperSol Technologies LLC., Hinoman Ltd.
Download The Full Report For Exclusive Market Findings:
Which Region Is Projected To Lead The Hemochromatosis (Iron Overload) Disease Treatment Market During The Forecast Period?
North America was the largest region in the hemochromatosis (Iron Overload) disease treatment market in 2024. The regions covered in the hemochromatosis (iron overload) disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Hemochromatosis (Iron Overload) Disease Treatment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=13151&type=smp
Browse Through More Reports Similar to the Global Hemochromatosis (Iron Overload) Disease Treatment Market 2025, By The Business Research Company
Sickle Cell Disease Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/sickle-cell-disease-treatment-global-market-report
Inflammatory Bowel Disease Treatment Global Market Report 2025
Crohns Disease Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model